Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
129.40
-1.62 (-1.24%)
At close: Aug 13, 2025, 4:00 PM
129.20
-0.20 (-0.15%)
After-hours: Aug 13, 2025, 7:54 PM EDT
Abbott Laboratories Stock Forecast
Stock Price Forecast
According to 19 professional analysts, the 12-month price target for Abbott Laboratories stock ranges from a low of $120 to a high of $160. The average analyst price target of $142.79 forecasts a 10.35% increase in the stock price over the next year.
Price Target: $142.79 (+10.35%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Abbott Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 8 | 8 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $147 → $142 | Buy | Maintains | $147 → $142 | +9.74% | Jul 18, 2025 |
| Raymond James | Raymond James | Buy Maintains $142 → $141 | Buy | Maintains | $142 → $141 | +8.96% | Jul 18, 2025 |
| Mizuho | Mizuho | Hold Maintains $140 → $135 | Hold | Maintains | $140 → $135 | +4.33% | Jul 18, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $143 → $145 | Hold → Strong Buy | Upgrades | $143 → $145 | +12.06% | Jul 18, 2025 |
| BTIG | BTIG | Strong Buy Maintains $148 → $145 | Strong Buy | Maintains | $148 → $145 | +12.06% | Jul 18, 2025 |
Financial Forecast
Revenue This Year
45.14B
from 41.95B
Increased by 7.60%
Revenue Next Year
48.68B
from 45.14B
Increased by 7.84%
EPS This Year
5.21
from 7.64
Decreased by -31.78%
EPS Next Year
5.74
from 5.21
Increased by 10.20%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.2B | 51.3B | 55.8B | ||
| Avg | 45.1B | 48.7B | 52.3B | ||
| Low | 43.5B | 46.2B | 48.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.6% | 13.7% | 14.6% | ||
| Avg | 7.6% | 7.8% | 7.4% | ||
| Low | 3.7% | 2.2% | -0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.46 | 6.11 | 6.88 | ||
| Avg | 5.21 | 5.74 | 6.34 | ||
| Low | 5.00 | 5.45 | 5.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -28.5% | 17.3% | 19.8% | ||
| Avg | -31.8% | 10.2% | 10.4% | ||
| Low | -34.6% | 4.5% | 2.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.